Answers are grounded in this paper and cite their sources.
The pharmacological management of hyperkalemia traditionally considered calcium or sodium polystyrene sulfonate (SPS) and, since recently, the novel binders patiromer and sodium zirconium cyclosilicate (SZC). We evaluated their patterns of use, duration of treatment and relative effectiveness/safety in Swedish routine care.
No takes yet. Share an insight, caveat, or question.
Ortiz et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: